
Are you ready to turn complex EMEA month- and quarter-end closes into clear, trusted results that power decisions for life-changing medicines? Based in Dublin, you will join a high-performing Global Financial Services Controlling team that steers the close for a portfolio of EMEA entities and ensures on-time delivery of local statutory audits. Your work will convert data into insight, elevate controls, and support leaders as they invest in therapies that matter.
You will own end-to-end Record to Report for designated entities and partner across finance, operations and our outsourced provider to deliver accurate, timely results. This role blends technical excellence in IFRS, US GAAP and local GAAP with practical problem-solving and continuous improvement. You will thrive in a dynamic, growth environment, build strong relationships across borders, and help shape how we scale with integrity. How will you strengthen our close, simplify processes and accelerate insight?
Accountabilities:
Why AstraZeneca: Here, finance is a catalyst for impact. You will be close to the mission of transforming the lives of people with rare and devastating diseases, working with cutting-edge tools and collaborating across borders to deliver trustworthy results at pace. We bring unexpected teams together to solve hard problems with integrity, valuing different perspectives and the power of connection. You will grow in a supportive, energizing environment that values kindness alongside ambition, where your expertise in controls, compliance and insight helps shape decisions that reach patients faster.
13-Oct-2026
29-Oct-2026
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy